Abstract
There are no studies on HLA analysis in patients in whom Graves’ disease (GD) hyperthyroidism has been preceded by ≥1 stressful event. The aim of the present study was to identify predisposing or protecting HLA alleles and their effects on the course of GD in this subset of patients. We performed serological HLA typing in 58 Caucasian patients with stress-related GD and in 130 matched healthy controls (HC). We also performed genomic HLA typing in 20/58 patients and in all HC. Five HLA alleles and three loci were more frequent in patients compared to HC: B8, Cw7, C*07, C*17, DR3, DR4, DRB1*04, and DQ2. In contrast, B14 was less frequent in patients than in HC. Depending on outcome after ATD withdrawal (remission, exacerbation on-ATD, relapse off-ATD), in patients, some alleles/loci were over-represented, while others were under-represented. Age, FT3, and FT4 fold increase over the upper normal limit at onset were different depending on the allele/locus carried. In GD patients with stress-triggered hyperthyroidism, HLA typing may be helpful in predicting the outcome of the disease after ATD withdrawal.
Similar content being viewed by others
References
R.S. Bahn, H.B. Burch, D.S. Cooper, J.R. Garber, M.C. Greenlee, I. Klein, P. Laurberg, I.R. McDougall, V.M. Montori, S.A. Rivkees, D.S. Ross, J.A. Sosa, M.N. Stan, American Thyroid Association, American Association of Clinical Endocrinologists, Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 21, 593–646 (2011). Erratum in: Thyroid. 21, 1169 (2011). Thyroid. 22:1195 (2012)
M.P. Vanderpump, The epidemiology of thyroid disease. Br. Med. Bull. 99, 39–51 (2011)
J. Heward, S.C. Gough, Genetic susceptibility to the development of autoimmune disease. Clin. Sci. (Lond) 93, 479–491 (1997)
F. Guarneri, S. Benvenga, Environmental factors and genetic background that interact to cause autoimmune thyroid disease. Curr. Opin. Endocrinol. Diabetes Obes. 14, 398–409 (2007)
Y. Tomer, Genetic susceptibility to autoimmune thyroid disease: past, present, and future. Thyroid 20, 715–725 (2010)
G. Effraimidis, W.M. Wiersinga, Mechanisms in endocrinology: autoimmune thyroid disease: old and new players. Eur. J. Endocrinol. 170, R241–R252 (2014)
R. Vita, D. Lapa, F. Trimarchi, S. Benvenga, Stress triggers the onset and the recurrences of hyperthyroidism in patients with Graves’ disease. Endocrine 48, 254–263 (2015)
B. Winsa, A. Karlsson, R. Bergstrom, H.O. Adami, A. Gamstedt, R. Jansson, U. Adamson, P.A. Dahlberg, Stressful life events and Graves’ disease. Lancet 338, 1475–1479 (1991)
N. Sonino, M.E. Girelli, M. Boscaro, F. Fallo, B. Busnardo, G.A. Fava, Life events in the pathogenesis of Graves’ disease. A controlled study. Acta Endocrinol. (Copenh) 128, 293–296 (1993)
A.W. Kung, Life events, daily stresses and coping in patients with Graves’ disease. Clin Endocrinol. (Oxf) 42, 303–308 (1995)
V.R. Radosavljević, S.M. Janković, J.M. Marinković, Stressful life events in the pathogenesis of Graves’ disease. Eur. J. Endocrinol. 134, 699–701 (1996)
K. Yoshiuchi, H. Kumano, S. Nomura, H. Yoshimura, K. Ito, Y. Kanaji, Y. Ohashi, T. Kuboki, H. Suematsu, Stressful life events and smoking were associated with Graves’ disease in women, but not in men. Psychosom. Med. 60, 182–185 (1998)
R.C. Martin, Triggering role of emotional stress and childbirth. Unexpected occurrence of Graves’ disease compared to 96 cases of Hashimoto thyroiditis and 97 cases of thyroid nodules. Ann. Endocrinol. 59, 107–112 (1998)
A. Matos-Santos, E.L. Nobre, J.G.E. Costa, P.J. Nogueira, A. Macedo, A. Galvão-Teles, J.J. De Castro, Relationship between the number and impact of stressful life events and the onset of Graves’ disease and toxic nodular goitre. Clin. Endocrinol. (Oxf) 55, 15–19 (2001)
M. Bagnasco, I. Bossert, G. Pesce, Stress and autoimmune thyroid diseases. Neuroimmunomodulation 13, 309–317 (2006)
L. Chiovato, M. Marinò, G. Perugi, E. Fiore, L. Montanelli, P. Lapi, E. Cavaliere, M. Ciampi, A. Patronelli, G. Placidi, G.F. Placidi, G.B. Cassano, A. Pinchera, Chronic recurrent stress due to panic disorder does not precipitate Graves’ disease. J. Endocrinol. Invest. 21, 758–764 (1998)
X.G. Vos, N. Smit, E. Endert, J.F. Brosschot, J.G.P. Tijssen, W.M. Wiersinga, Age and stress as determinants of the severity of hyperthyroidism caused by Graves’ disease in newly diagnosed patients. Eur. J. Endocrinol. 160, 193–199 (2009)
G. Falgarone, H.M. Heshmati, R. Cohen, G. Reach, Mechanisms in endocrinology. Role of emotional stress in the pathophysiology of Graves’ disease. Eur. J. Endocrinol. 168, R13–R18 (2012)
T.H. Brix, L. Hegedus, Twin studies as a model for exploring the aetiology of autoimmune thyroid disease. Clin. Endocrinol. (Oxf) 76, 457–464 (2012)
T.F. Davies, R. Latif, X. Yin, New genetic insights from autoimmune thyroid disease. J. Thyroid Res. 2012, 623852 (2012)
M.J. Simmonds, S.C. Gough, Genetic insights into disease mechanisms of autoimmunity. Br. Med. Bull. 71, 93–113 (2005)
K.F. Tait, S.C. Gough, The genetics of autoimmune endocrine disease. Clin. Endocrinol. (Oxf) 59, 1–11 (2003)
A.P. Weetman, L. Zhang, N. Tandon, O.M. Edwards, HLA associations with autoimmune Addison’s disease. Tissue Antigens 38, 31–33 (1991)
R.R. Graham, W.A. Ortmann, C.D. Langefeld, D. Jawaheer, S.A. Selby, P.R. Rodine, E.C. Baechler, K.E. Rohlf, K.B. Shark, K.J. Espe, L.E. Green, R.P. Nair, P.E. Stuart, J.T. Elder, R.A. King, K.L. Moser, P.M. Gaffney, T.L. Bugawan, H.A. Erlich, S.S. Rich, P.K. Gregersen, T.W. Behrens, Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am. J. Hum. Genet. 71, 543–553 (2002)
E.M. Jacobson, A. Huber, Y. Tomer, The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J. Autoimmun. 30, 58–62 (2008)
M.J. Simmonds, J.M. Howson, J.M. Heward, H.J. Cordell, H. Foxall, J. Carr-Smith, S.M. Gibson, N. Walker, Y. Tomer, J.A. Franklyn, J.A. Todd, S.C. Gough, Regression mapping of association between the human leukocyte antigen region and Graves disease. Am. J. Hum. Genet. 76, 157–163 (2005)
A.A. Zeitlin, J.M. Heward, P.R. Newby, J.D. Carr-Smith, J.A. Franklyn, S.C. Gough, M.J. Simmonds, Analysis of HLA class II genes in Hashimoto’s thyroiditis reveals differences compared to Graves’ disease. Genes Immun. 9, 358–363 (2008)
N.R. Farid, C. Thompson, HLA and autoimmune endocrine disease 1985. Mol. Biol. Med. 3, 85–97 (1986)
S.M. McLachlan, H.A. Aliesky, C.R. Chen, R.W. Williams, B. Rapoport, Exceptional hyperthyroidism and a role for both major histocompatibility class I and class II genes in a murine model of Graves’ disease. PLoS One 6, e21378 (2011)
S.M. McLachlan, H. Aliesky, B. Banuelos, J. Magana, R.W. Williams, B. Rapoport, Immunoglobulin heavy chain variable region and major histocompatibility region genes are linked to induced graves’ disease in females from two very large families of recombinant inbred mice. Endocrinology 155, 4094–4103 (2014)
P. Laurberg, G. Wallin, L. Tallstedt, M. Abraham-Nordling, G. Lundell, O. Tørring, TSH-receptor autoimmunity in Graves’ disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. Eur. J. Endocrinol. 158, 69–75 (2008)
N.R. Farid, J.M. Barnard, W.H. Marshall, The association of HLA with autoimmune thyroid disease in Newfoundland. The influence of HLA homozygosity in Graves’ disease. Tissue Antigens 8, 181–189 (1976)
P.A. Dahlberg, G. Holmlund, F.A. Karlsson, J. Safwenberg, HLA-A, -B, -C and -DR antigens in patients with Graves’ disease and their correlation with signs and clinical course. Acta Endocrinol. (Copenh) 97, 42–47 (1981)
V. Stenszky, L. Kozma, C. Balazs, J.C. Bear, N.R. Farid, The role of HLA antigens in the manifestation and course of Graves’ disease. Mol. Biol. Med. 3, 53–62 (1986)
K. Bech, B. Lumholtz, J. Nerup, M. Thomsen, P. Platz, L.P. Ryder, A. Svejgaard, K. Siersbaek-Nielsen, J.M. Hansen, J.H. Larsen, HLA antigens in Graves’ disease. Acta Endocrinol. (Copenh) 86, 510–516 (1977)
D.S. Singer, E. Mozes, S. Kirshner, L.D. Kohn, Role of MHC class I molecules in autoimmune disease. Crit. Rev. Immunol. 17, 463–468 (1997)
L.J. Albert, R.D. Inman, Molecular mimicry and autoimmunity. N. Engl. J. Med. 341, 2068–2074 (1999)
J.B. Jaspan, K. Sullivan, R.F. Garry, M. Lopez, M. Wolfe, S. Clejan, C. Yan, S. Tenenbaum, D.M. Sander, B. Ahmed, M. Bryer-Ash, The interaction of a type A retroviral particle and class II human leukocyte antigen susceptibility genes in the pathogenesis of Graves’ disease. J. Clin. Endocrinol. Metab. 81, 2271–2279 (1996)
R. Vita, F. Guarneri, R. Agah, S. Benvenga, Autoimmune thyroid disease elicited by NY-ESO-1 vaccination. Thyroid 24, 390–394 (2014)
E. Gregoric, J.A. Gregoric, F. Guarneri, S. Benvenga, Injections of Clostridium botulinum neurotoxin A may cause thyroid complications in predisposed persons based on molecular mimicry with thyroid autoantigens. Endocrine 39, 41–47 (2011)
F. Guarneri, D. Carlotta, G. Saraceno, F. Trimarchi, S. Benvenga, Bioinformatics support the possible triggering of autoimmune thyroid diseases by Yersinia enterocolitica outer membrane proteins homologous to the human thyrotropin receptor. Thyroid 21, 1283–1284 (2011)
A. Marangou, F. Guarneri, S. Benvenga, Graves’ disease precipitated by rickettsial infection. Endocrine 50, 828–829 (2015)
S. Benvenga, L. Santarpia, F. Trimarchi, F. Guarneri, Human thyroid autoantigens and proteins of Yersinia and Borrelia share amino acid sequence homology that includes binding motifs to HLA-DR molecules and T-cell receptor. Thyroid 16, 225–236 (2006)
M.J. Simmonds, J.M. Howson, J.M. Heward, J. Carr-Smith, J.A. Franklyn, J.A. Todd, S.C. Gough, A novel and major association of HLA-C in Graves’ disease that eclipses the classical HLA-DRB1 effect. Hum. Mol. Genet. 16, 2149–2153 (2007)
A. Huber, F. Menconi, S. Corathers, E.M. Jacobson, Y. Tomer, Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr. Rev. 29, 697–725 (2008)
Q.Y. Chen, W. Huang, J.X. She, F. Baxter, R. Volpe, N.K. Maclaren, HLA-DRB1*08, DRB1*03/DRB3*0101, and DRB3*0202 are susceptibility genes for Graves’ disease in North American Caucasians, whereas DRB1*07 is protective. J. Clin. Endocrinol. Metab. 84, 3182–3186 (1999)
H.J. Lee, C.W. Li, S.S. Hammerstad, M. Stefan, Y. Tomer, Immunogenetics of autoimmune thyroid diseases: a comprehensive review. J. Autoimmun. 64, 82–90 (2015)
A. Petrone, G. Giorgi, C.A. Mesturino, M. Capizzi, I. Cascino, L. Nistico, J. Osborn, U. Di Mario, R. Buzzetti, Association of DRB1*04-DQB1*0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto’s thyroiditis in an Italian population. Thyroid 11, 171–175 (2001)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Vita, R., Lapa, D., Trimarchi, F. et al. Certain HLA alleles are associated with stress-triggered Graves’ disease and influence its course. Endocrine 55, 93–100 (2017). https://doi.org/10.1007/s12020-016-0909-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-016-0909-6